+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Controlled Release Drug Delivery Market by Release Mechanism (Activation-Modulated Drug Delivery Systems, Chemically Activated, Feedback Regulated Drug Delivery Systems), Technology (Coacervation, Implants, Micro Encapsulation), Application - Forecast 2024-2030- Product Image
Global Controlled Release Drug Delivery Market by Release Mechanism (Activation-Modulated Drug Delivery Systems, Chemically Activated, Feedback Regulated Drug Delivery Systems), Technology (Coacervation, Implants, Micro Encapsulation), Application - Forecast 2024-2030- Product Image
Sale

Global Controlled Release Drug Delivery Market by Release Mechanism (Activation-Modulated Drug Delivery Systems, Chemically Activated, Feedback Regulated Drug Delivery Systems), Technology (Coacervation, Implants, Micro Encapsulation), Application - Forecast 2024-2030

  • PDF Icon

    Report

  • 182 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5337450
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Controlled Release Drug Delivery Market size was estimated at USD 43.07 billion in 2023, USD 46.70 billion in 2024, and is expected to grow at a CAGR of 9.17% to reach USD 79.62 billion by 2030.

Controlled-release drug delivery refers to systems that release the active ingredient of a drug at a predictable and controllable rate. This approach to drug delivery ensures a steady level of medication in the bloodstream, reduces the frequency of dosing, and can improve patient compliance. The market for controlled-release drug delivery is defined by products and technologies that accomplish these objectives across various applications and end-use scenarios. Applications for controlled-release drug delivery span multiple therapeutic areas, such as diabetes, cardiovascular diseases, CNS disorders, pain management, and oncology.

Challenges affecting the growth of the controlled-release drug delivery market involve High costs associated with developing new drug delivery systems and Technical challenges in formulating controlled-release drug delivery systems for certain drugs. The market is witnessing the advancement of precision medicine approaches that enable the creation of tailored drug delivery systems for individual patient needs. Additionally, there is an apparent momentum in emerging markets where the expansion of healthcare infrastructures and improved access to pharmaceuticals are generating new opportunities for controlled-release technologies. Furthermore, the landscape is being reshaped by strategic partnerships between pharmaceutical enterprises and drug-delivery technology firms, fostering innovation and the development of sophisticated, more effective drug-delivery mechanisms.

Regional Insights

The controlled-release drug delivery market in the Americas, particularly North America, is well-established due to the presence of key pharmaceutical companies and advanced healthcare infrastructure. The United States holds a significant position in the market, owing to FDA support for novel drug delivery systems and a higher prevalence of chronic diseases, which necessitate prolonged drug administration. Europe holds a substantial share in the controlled release drug delivery market, with a strong regulatory framework governed by the European Medicines Agency (EMA). The market benefits from favorable government healthcare policies and the rise of generics due to patent cliffs.

The Middle East and Africa exhibit potential growth due to economic development, investment in healthcare infrastructure, and increasing accessibility to advanced treatment options. Asia-Pacific is expected to experience rapid growth in the controlled-release drug delivery sector due to the expanding pharmaceutical industry and rising healthcare expenditure in countries such as China and India. There is an increasing focus on addressing the unmet medical needs of a large patient population. Partnerships between local and international players and governmental support in promoting generic drug use offer growth opportunities in this region.

Market Trends by Segment

  • Release Mechanism: Increasing R&D activities for development of robust chemically activated system
  • Technology: Integration of targeted delivery to increase therapeutic index and reducing side effects
  • Application: Rising preference for injectable controlled-release drug delivery systems for chronic disease management

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

DelSiTech Announces Closing of EUR 10 Million Financing Round to Advance its Silica-Based Drug Delivery Technology Platform

DelSiTech received EUR 10 million (USD 10.87 million) in funding primarily sourced from new stakeholders, including DRW Venture Capital LLC of Chicago and Tolmar International Ltd of Dublin, contributing a combined total exceeding EUR 9 million (USD 9.78 million). This influx of investment is a testament to DelSiTech's stature as an innovator in controlled-release drug delivery technologies, fortified by its proprietary Silica Matrix platform and a promising drug development pipeline. Poised for future success, this financial milestone is poised to propel DelSiTech closer to meeting strategic business milestones, fueled by burgeoning revenues and a commitment to satisfying critical clinical needs for patient welfare.

Chiesi Global Rare Diseases and Aliada Therapeutics Partner to Advance Blood-Brain Barrier-Crossing Platform Technology for Drug Delivery

Chiesi Global Rare Diseases, part of the Chiesi Group, has partnered with Aliada Therapeutics to advance the treatment of lysosomal storage disorders using a new blood-brain barrier traversal technology. This collaboration capitalizes on Aliada's pioneering Modular Delivery (MODEL) platform, which exploits natural cellular transport processes within the brain's vascular cells to transfer large-molecule treatments into the central nervous system. This partnership signals a significant step forward in developing controlled-release drug delivery systems, potentially substantially improving therapeutic outcomes for patients afflicted with these complex conditions.

Key Company Profiles

The report delves into recent significant developments in the Controlled Release Drug Delivery Market, highlighting leading vendors and their innovative profiles. These include Adare Pharma Solutions, Alkermes PLC, AMW GmbH, AstraZeneca PLC, Avantor, Inc., Baxter International Inc., Becton, Dickinson and Company, Biogen Inc., Boehringer Ingelheim International GmbH, Catalent, Inc., Celanese Corporation, Celares GmbH, Coating Place, Inc., Collegium Pharmaceutical, Inc., Colorcon, Inc., Corium, Inc., CURE Pharmaceutical, GlaxoSmithKline PLC, Insulet Corporation, Johnson & Johnson Services, Inc., Lonza Group Ltd., Medtronic PLC, Merck & Co., Inc., Pensatech Pharma GmbH, Pfizer Inc., Seqens, Tandem Diabetes Care, Inc., and Trelleborg AB.

This research report offers invaluable insights into various crucial aspects of the Controlled Release Drug Delivery Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increase in Need for Controlled Release Dosage Forms for the Infants and Geriatric Population
5.1.1.2. Rising Adoption of Hydrogel and Osmotic Controlled Drug Delivery System
5.1.1.3. Need to Improve the Therapeutic Benefits, Reduce Drug Toxicity to Control Various Types of Illness
5.1.2. Restraints
5.1.2.1. Complex Manufacturing Process of Controlled Release Drug Delivery System
5.1.3. Opportunities
5.1.3.1. Potential Development of Nanotechnology in Advanced Medicine/Drug Formulations for Controlled-Release Drug Delivery System
5.1.3.2. Advances in Control Release Drug Delivery System
5.1.4. Challenges
5.1.4.1. Potential limitation of controlled drug release formulation
5.2. Market Segmentation Analysis
5.2.1. Release Mechanism: Increasing R&D activities for development of robust chemically activated system
5.2.2. Technology: Integration of targeted delivery to increase therapeutic index and reducing side effects
5.2.3. Application: Rising preference for injectable controlled-release drug delivery systems for chronic disease management
5.3. Market Trend Analysis
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter’s Five Forces Analysis
5.6.1. Threat of New Entrants
5.6.2. Threat of Substitutes
5.6.3. Bargaining Power of Customers
5.6.4. Bargaining Power of Suppliers
5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework Analysis
5.9. Client Customization
6. Controlled Release Drug Delivery Market, by Release Mechanism
6.1. Introduction
6.2. Activation-Modulated Drug Delivery Systems
6.3. Chemically Activated
6.4. Feedback Regulated Drug Delivery Systems
6.5. Micro Reservoir Partition Controlled Drug Delivery Systems
6.6. Polymer Based Systems
7. Controlled Release Drug Delivery Market, by Technology
7.1. Introduction
7.2. Coacervation
7.3. Implants
7.4. Micro Encapsulation
7.5. Targeted Delivery
7.6. Transdermal
7.7. Wurster Technique
8. Controlled Release Drug Delivery Market, by Application
8.1. Introduction
8.2. Drug Eluting Stents
8.3. Infusion Pumps
8.4. Injectable
8.5. Metered Dose Inhalers
8.6. Oral Controlled-Drug Delivery Systems
8.7. Transdermal & Ocular Patches
9. Americas Controlled Release Drug Delivery Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Controlled Release Drug Delivery Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Controlled Release Drug Delivery Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. DelSiTech Announces Closing of EUR 10 Million Financing Round to Advance its Silica-Based Drug Delivery Technology Platform
12.3.2. Chiesi Global Rare Diseases and Aliada Therapeutics Partner to Advance Blood-Brain Barrier-Crossing Platform Technology for Drug Delivery
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. CONTROLLED RELEASE DRUG DELIVERY MARKET RESEARCH PROCESS
FIGURE 2. CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CONTROLLED RELEASE DRUG DELIVERY MARKET DYNAMICS
FIGURE 7. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2023 VS 2030 (%)
FIGURE 8. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 10. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. CONTROLLED RELEASE DRUG DELIVERY MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. CONTROLLED RELEASE DRUG DELIVERY MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. CONTROLLED RELEASE DRUG DELIVERY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY HYDRODYNAMIC PRESSURE ACTIVATED, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY HYDRODYNAMIC PRESSURE ACTIVATED, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MAGNETICALLY ACTIVATED, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MAGNETICALLY ACTIVATED, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MECHANICALLY ACTIVATED, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MECHANICALLY ACTIVATED, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY OSMOTIC PRESSURE ACTIVATED, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY OSMOTIC PRESSURE ACTIVATED, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY VAPOR PRESSURE ACTIVATED, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY VAPOR PRESSURE ACTIVATED, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ENZYME ACTIVATED, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ENZYME ACTIVATED, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY HYDROLYSIS ACTIVATED, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY HYDROLYSIS ACTIVATED, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY PH ACTIVATED, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY PH ACTIVATED, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY FEEDBACK REGULATED DRUG DELIVERY SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY FEEDBACK REGULATED DRUG DELIVERY SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICRO RESERVOIR PARTITION CONTROLLED DRUG DELIVERY SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICRO RESERVOIR PARTITION CONTROLLED DRUG DELIVERY SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY POLYMER BASED SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY POLYMER BASED SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COACERVATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COACERVATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY IMPLANTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY IMPLANTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICRO ENCAPSULATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICRO ENCAPSULATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TARGETED DELIVERY, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TARGETED DELIVERY, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL, BY REGION, 2024-2030 (USD MILLION)
TABLE 51. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY WURSTER TECHNIQUE, BY REGION, 2018-2023 (USD MILLION)
TABLE 52. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY WURSTER TECHNIQUE, BY REGION, 2024-2030 (USD MILLION)
TABLE 53. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 54. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 55. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY DRUG ELUTING STENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 56. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY DRUG ELUTING STENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 57. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2018-2023 (USD MILLION)
TABLE 58. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2024-2030 (USD MILLION)
TABLE 59. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2023 (USD MILLION)
TABLE 60. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY INJECTABLE, BY REGION, 2024-2030 (USD MILLION)
TABLE 61. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY METERED DOSE INHALERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 62. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY METERED DOSE INHALERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 63. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ORAL CONTROLLED-DRUG DELIVERY SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
TABLE 64. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ORAL CONTROLLED-DRUG DELIVERY SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
TABLE 65. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL & OCULAR PATCHES, BY REGION, 2018-2023 (USD MILLION)
TABLE 66. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL & OCULAR PATCHES, BY REGION, 2024-2030 (USD MILLION)
TABLE 67. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
TABLE 68. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
TABLE 69. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
TABLE 70. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
TABLE 71. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
TABLE 72. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
TABLE 73. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 74. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 75. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 76. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 77. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 78. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 79. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
TABLE 80. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
TABLE 81. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
TABLE 82. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
TABLE 83. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
TABLE 84. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
TABLE 85. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 86. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 87. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 88. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 89. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
TABLE 90. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
TABLE 91. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
TABLE 92. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
TABLE 93. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
TABLE 94. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
TABLE 95. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 96. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 97. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 98. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 99. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
TABLE 100. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
TABLE 101. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
TABLE 102. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
TABLE 103. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
TABLE 104. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
TABLE 105. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 106. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 107. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 108. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 109. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
TABLE 110. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
TABLE 111. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
TABLE 112. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
TABLE 113. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
TABLE 114. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
TABLE 115. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 116. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 117. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 118. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 119. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
TABLE 120. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
TABLE 121. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
TABLE 122. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
TABLE 123. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
TABLE 124. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
TABLE 125. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 126. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 127. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 128. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 129. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 130. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 131. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
TABLE 132. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
TABLE 133. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
TABLE 134. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
TABLE 135. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
TABLE 136. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
TABLE 137. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 138. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 139. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 140. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 141. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 142. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 143. AUSTRALIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
TABLE 144. AUSTRALIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
TABLE 145. AUSTRALIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
TABLE 146. AUSTRALIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
TABLE 147. AUSTRALIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
TABLE 148. AUSTRALIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
TABLE 149. AUSTRALIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 150. AUSTRALIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 151. AUSTRALIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 152. AUSTRALIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 153. CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
TABLE 154. CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
TABLE 155. CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
TABLE 156. CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
TABLE 157. CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
TABLE 158. CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
TABLE 159. CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 160. CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 161. CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 162. CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 163. INDIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
TABLE 164. INDIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
TABLE 165. INDIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
TABLE 166. INDIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
TABLE 167. INDIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
TABLE 168. INDIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
TABLE 169. INDIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 170. INDIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 171. INDIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 172. INDIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 173. INDONESIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
TABLE 174. INDONESIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
TABLE 175. INDONESIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
TABLE 176. INDONESIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
TABLE 177. INDONESIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
TABLE 178. INDONESIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
TABLE 179. INDONESIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 180. INDONESIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 181. INDONESIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 182. INDONESIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 183. JAPAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
TABLE 184. JAPAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
TABLE 185. JAPAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
TABLE 186. JAPAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
TABLE 187. JAPAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
TABLE 188. JAPAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
TABLE 189. JAPAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 190. JAPAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 191. JAPAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 192. JAPAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 193. MALAYSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
TABLE 194. MALAYSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
TABLE 195. MALAYSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
TABLE 196. MALAYSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
TABLE 197. MALAYSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
TABLE 198. MALAYSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
TABLE 199. MALAYSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 200. MALAYSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 201. MALAYSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 202. MALAYSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 203. PHILIPPINES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
TABLE 204. PHILIPPINES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
TABLE 205. PHILIPPINES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
TABLE 206. PHILIPPINES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
TABLE 207. PHILIPPINES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
TABLE 208. PHILIPPINES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
TABLE 209. PHILIPPINES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 210. PHILIPPINES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 211. PHILIPPINES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 212. PHILIPPINES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 213. SINGAPORE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
TABLE 214. SINGAPORE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
TABLE 215. SINGAPORE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
TABLE 216. SINGAPORE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
TABLE 217. SINGAPORE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
TABLE 218. SINGAPORE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
TABLE 219. SINGAPORE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 220. SINGAPORE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 221. SINGAPORE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 222. SINGAPORE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 223. SOUTH KOREA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
TABLE 224. SOUTH KOREA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
TABLE 225. SOUTH KOREA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
TABLE 226. SOUTH KOREA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
TABLE 227. SOUTH KOREA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
TABLE 228. SOUTH KOREA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
TABLE 229. SOUTH KOREA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 230. SOUTH KOREA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 231. SOUTH KOREA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 232. SOUTH KOREA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 233. TAIWAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
TABLE 234. TAIWAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
TABLE 235. TAIWAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
TABLE 236. TAIWAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
TABLE 237. TAIWAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
TABLE 238. TAIWAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
TABLE 239. TAIWAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 240. TAIWAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 241. TAIWAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 242. TAIWAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 243. THAILAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
TABLE 244. THAILAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
TABLE 245. THAILAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
TABLE 246. THAILAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
TABLE 247. THAILAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
TABLE 248. THAILAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
TABLE 249. THAILAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 250. THAILAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 251. THAILAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 252. THAILAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 253. VIETNAM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
TABLE 254. VIETNAM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
TABLE 255. VIETNAM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
TABLE 256. VIETNAM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
TABLE 257. VIETNAM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
TABLE 258. VIETNAM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
TABLE 259. VIETNAM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 260. VIETNAM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 261. VIETNAM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 262. VIETNAM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 275. DENMARK CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
TABLE 276. DENMARK CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
TABLE 277. DENMARK CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
TABLE 278. DENMARK CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
TABLE 279. DENMARK CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
TABLE 280. DENMARK CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
TABLE 281. DENMARK CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLIO

Companies Mentioned

  • Adare Pharma Solutions
  • Alkermes PLC
  • AMW GmbH
  • AstraZeneca PLC
  • Avantor, Inc.
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Biogen Inc.
  • Boehringer Ingelheim International GmbH
  • Catalent, Inc.
  • Celanese Corporation
  • Celares GmbH
  • Coating Place, Inc.
  • Collegium Pharmaceutical, Inc.
  • Colorcon, Inc.
  • Corium, Inc.
  • CURE Pharmaceutical
  • GlaxoSmithKline PLC
  • Insulet Corporation
  • Johnson & Johnson Services, Inc.
  • Lonza Group Ltd.
  • Medtronic PLC
  • Merck & Co., Inc.
  • Pensatech Pharma GmbH
  • Pfizer Inc.
  • Seqens
  • Tandem Diabetes Care, Inc.
  • Trelleborg AB

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages182
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 46.7 Billion
Forecasted Market Value ( USD ) by 2030 $ 79.62 Billion
Compound Annual Growth Rate9.1%
Regions CoveredGlobal
No. of Companies Mentioned28

Related Topics

Related Reports

Controlled Release Drug Delivery Market Size, Share & Trends Analysis Report, By Technology (Targeted Delivery, Transdermal), By Release Mechanism, By Application, By Region, And Segment Forecasts, 2023-2030 - Product Image

Controlled Release Drug Delivery Market Size, Share & Trends Analysis Report, By Technology (Targeted Delivery, Transdermal), By Release Mechanism, By Application, By Region, And Segment Forecasts, 2023-2030

  • Report
  • 120 Pages
  • Global
From
Controlled Release Drug Delivery Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030 - Product Image

Controlled Release Drug Delivery Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030

  • Report
  • 146 Pages
  • Global
From
Global Controlled Release Drug Delivery Market Size, Share & Industry Trends Analysis Report By Release Mechanism, By Technology, By Application, By Regional Outlook and Forecast, 2023 - 2030 - Product Image

Global Controlled Release Drug Delivery Market Size, Share & Industry Trends Analysis Report By Release Mechanism, By Technology, By Application, By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • 355 Pages
  • Global
From
Controlled Release Drug Delivery - Global Strategic Business Report - Product Image

Controlled Release Drug Delivery - Global Strategic Business Report

  • Report
  • 93 Pages
  • Global
From
Global Controlled Release Drug Delivery Market Report and Forecast 2024-2032 - Product Image

Global Controlled Release Drug Delivery Market Report and Forecast 2024-2032

  • Report
  • 140 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.